ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Pro-Inflammatory Actions of New Non-HLA Antibodies Targeting Protease-Activated Receptor (PAR-1)

    R. Catar,1 C. Luecht,1 M. Simon,1 A. Philippe,1 A. Kusch,1 M. Szczepek,2 P. Hildebrand,2 P. Scheerer,2 D. Dragun.1

    1Nephrology and Intensive Care Medicine, Charité, Berlin, Germany; 2Institute of Medical Physics and Biophysics, Charité, Berlin, Germany.

    Microvascular endothelium is major target for antibodies directed against HLA and non-HLA antigens. Functional antibodies targeting G-protein coupled receptors (GPCRs) such as AT1R or ETAR…
  • 2015 American Transplant Congress

    Pharmacogenetic Variation in Renal Calcineurin Inhibitor (CNI) Metabolism and the Response of Allograft-Derived Proximal Tubule Cells

    N. Knops,1,2 L. van den Heuvel,2 R. Masereeuw,3 H. de Loor,4 E. Levtchenko,1,2 D. Kuypers.5,4

    1Pediatric Nephrology and Solid Organ Transplantation, University Hospitals Leuven, Leuven, Belgium; 2Laboratory for Pediatrics, Dept. Development & Regeneration, KU Leuven, Leuven, Belgium; 3Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands; 4Laboratory of Nephrology, University Hospitals Leuven, Leuven, Belgium; 5Nephrology and Solid Organ Transplantation, University Hospital Leuven, Leuven, Belgium.

    Background: Multiple studies have demonstrated the importance of genetic variation in CYP3A5 and ABCB1 for calcineurin inhibitor (CNI) disposition and CNI-related nephrotoxicity. Renal CNI metabolism…
  • 2015 American Transplant Congress

    DNA Methylation Classifier Associates With Long-Term Graft Function Post-Kidney Transplantation

    J. Suh,1 D. Maluf, K. Archer,2 T. Lee,1 L. Gallon,3 V. Mas.1

    1UVA, Charlottesville, VA; 2VCU, Richmond, VA; 3Noerthwestern University, Chicago, IL.

    "Background. Late graft failure is a major problem after kidney transplantation (KT) mainly due to chronic renal allograft dysfunction (CRAD). Data about common pathways of…
  • 2015 American Transplant Congress

    Inhibition of mTOR Modulates SLPI Expression: A Potential Role in Kidney Transplant Patients

    N. Ambrosi,1 A. Dotta,2 C. Pizarro,2 D. Guerrieri,1 A. Gonzalez,2 C. Leiva,2 L. Leon,2 J. Mendiberri,3 M. Rial,2 C. Incardona,4 E. Chuluyan,1 D. Casadei.2

    1CEFYBO, UBA, Buenos Aires, Argentina; 2Fundacion 3er Milenio, INBA, Buenos Aires, Argentina; 3UNICEN, Olavarria, Argentina; 4Fundación GADOR, Buenos Aires, Argentina.

    Secretory leukocyte protease inhibitor (SLPI) is a serine protease inhibitor secreted by inflammatory and epithelial cells. It functions as an endogenous immunomodulatory, with antiinflammatory and…
  • 2015 American Transplant Congress

    Clinical and Biochemical Results of BK Virus Nephropathy in Kidney Allograft Recipients

    B. Canbakan,1 I. Akdağ,1 ö. Merhametsiz,1 ö. Yayar,2 E. Oğuz,1 M. Kiliç,3 D. Ayli.1

    1Nephrology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey; 2Nephrology, Atatürk Training and Research Hospital, Ankara, Turkey; 3General Surgery, Atatürk Training and Research Hospital, Ankara, Turkey.

    BK virus (BKV) nephropathy has emerged as a significant cause of graft dysfuction in kidney allograft recipients after using powerful immunosupressive treatment protocols in recent…
  • 2015 American Transplant Congress

    Distinct Subtypes of Rejection in a Novel Non Human Primate Model of Sensitization

    C. Burghuber,1,2 J. Kwun,1,3 F. Leopardi,3 A. Gibby,1 A. Farris,1 N. Iwakoshi,1 S. Knechtle.1,3

    1Emory University, Atlanta, GA; 2Medical University Vienna, Vienna, Austria; 3Duke University, Durham, NC.

    [Background] Preformed and newly formed alloantibody post transplantation (TX) can significantly deteriorate graft survival. Patterns of humoral rejection in sensitized patients varies significantly due to…
  • 2015 American Transplant Congress

    Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End Stage Renal Disease (ESRD) Patients: A Multi-Level Mixed Modeling Approach

    K. Newman,1 S. Fedewa,1 M. Jacobson,1 A. Adams,2 R. Zhang,2 R. Patzer.1,2

    1Emory University Rollins School of Public Health, Atlanta; 2Emory University School of Medicine, Atlanta.

    Background: Racial disparities in access to kidney transplantation exist among End Stage Renal Disease (ESRD) patients, even after placement on the deceased donor waitlist. One…
  • 2015 American Transplant Congress

    Come Again? Part 2, Exploring Causes for Increased Rehospitalization in ECD Kidney Recipients

    C. Dunn, M. Hung, S. Greenstein.

    Surgery, Albert Einstein College of Medicine, Bronx, NY.

    Previously, we demonstrated that ECD kidney recipients had an increased rate of re-hospitalization within 1 year but not 2 years post-transplant . This was a…
  • 2015 American Transplant Congress

    Come Again? A Retrospective Cohort Study of Rehospitalization Following Expanded Criteria Donor Renal Transplantation

    M. Hung,1 C. Dunn,1 A. Holtzman,1 E. Bellin,2 S. Greenstein.2

    1Albert Einstein College of Medicine, Bronx, NY; 2Montefiore Medical Center, Bronx, NY.

    Though ECD kidneys are commonly used, they have an increased risk of graft failure, which is associated with rehospitalizations within thirty days post-transplant. Our aim…
  • 2015 American Transplant Congress

    Infectious Complications With Plasmapheresis in Combination With Antithymocyte Globulin Compared to Antithymocyte Globulin Alone in the Treatment of Acute Rejection

    A. Leino, A. Hulbert, A. Delahunty, A. Rajab, J. Von Visger, H. Winters.

    The Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH.

    Background: Due to the complex nature of acute rejection (AR), multiple therapeutic modalities are necessary to prevent graft loss. The combination of prolonged cell depletion…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences